Most of the patients were found to have one of the following autoantibodies, suggesting a post-COVID-19 autoimmune reaction: antineutrophil cytoplasmic antibodies [57], anti-cyclic citrullinated peptide (anti-CCP) with a majority of the antinuclear antibody (ANA), aCL, and anti-beta-2-glycoprotein-1 (anti-β2GP1) in association with a cytokine storm [58]. The gene discussed is APOH; the disease is COVID-19.